Biohaven Pharmaceutical News - BHVN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Biohaven Pharmaceutical Holding Company Ltd BHVN NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.73 1.5% 49.25 49.78 48.17 48.62 48.52 13:23:25
more quote information »

Recent News

Date Time Source Heading
11/12/20197:00IHNWFeatured Sugarmade Releases H1 2019 Data for Recent Acquisition, BZRTH: Over $15M Sales on 25% Sequential Revenue Growth
11/06/201909:02PRNUSKleo Pharmaceuticals Presents Preclinical Data Supporting..
11/05/201907:30PRNUSBiohaven Completes Enrollment In Pivotal Phase 2/3..
11/04/201918:43PRNUSBiohaven Statement Regarding Kleo Pharmaceuticals (Kleo): ..
11/01/201917:18EDGARQuarterly Report (10-q)
11/01/201916:30EDGARCurrent Report Filing (8-k)
11/01/201916:15PRNUSBiohaven Pharmaceuticals Reports Third Quarter 2019..
10/28/201907:30PRNUSBiohaven Completes Enrollment In Phase 3 Generalized Anxiety..
10/17/201918:30EDGARStatement of Changes in Beneficial Ownership (4)
10/03/201907:09EDGARCurrent Report Filing (8-k)
9/18/201907:30PRNUSBiohaven's Verdiperstat, An Oral Myeloperoxidase Inhibitor,..
9/13/201916:35EDGARStatement of Changes in Beneficial Ownership (4)
9/10/201907:30PRNUSBiohaven Advances NOJECTION™ Migraine Platform With..
9/09/201907:30PRNUSBiohaven Presents Data Demonstrating Reduction In..
9/04/201907:25EDGARCurrent Report Filing (8-k)
8/21/201916:12EDGARStatement of Changes in Beneficial Ownership (4)
8/19/201918:42EDGARInitial Statement of Beneficial Ownership (3)
8/09/201916:44EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/09/201916:33EDGARCurrent Report Filing (8-k)
8/09/201916:17EDGARQuarterly Report (10-q)
8/09/201906:47PRNUSBiohaven Pharmaceuticals Reports Second Quarter 2019..
8/08/201917:09EDGARCurrent Report Filing (8-k)
8/08/201917:02PRNUSBiohaven Pharmaceuticals Reports Second Quarter 2019..
8/07/201907:30PRNUSBiohaven Completes Enrollment In Pivotal Phase 3 Migraine..
7/31/201907:30PRNUSBiohaven Enrolls First Patient In Phase 3 Clinical Trial Of..
7/22/201907:30PRNUSBiohaven Provides Update On Phase 2/3 Alzheimer's Disease..
7/15/201907:30PRNUSBiohaven's Positive Phase 3 Trial of Rimegepant Zydis®..
7/11/201907:30PRNUSBiohaven Showcases Positive Data on Rimegepant, Oral CGRP..
7/10/201917:00PRNUSBiohaven's Rimegepant Positive Phase 3 Trial For Acute..
7/10/201916:27EDGARAmended Statement of Ownership (sc 13g/a)
7/01/201917:37EDGARStatement of Changes in Beneficial Ownership (4)
7/01/201917:36EDGARStatement of Changes in Beneficial Ownership (4)
7/01/201907:30PRNUSBiohaven Enrolls First Patient in Phase 2 Clinical Trial of..
6/28/201907:12EDGARStatement of Changes in Beneficial Ownership (4)
6/28/201907:10EDGARStatement of Changes in Beneficial Ownership (4)
6/24/201907:30PRNUSBiohaven To Present 16 Abstracts At 2019 American Headache..
6/21/201916:06EDGARCurrent Report Filing (8-k)
6/20/201916:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/18/201922:08PRNUSBiohaven Announces Pricing Of $300 Million Public Offering..
6/18/201906:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/17/201918:00PRNUSBiohaven Announces Proposed Public Offering Of Common Shares
6/17/201917:15EDGARAutomatic Shelf Registration Statement of Securities of..
5/23/201918:39EDGARStatement of Changes in Beneficial Ownership (4)
5/23/201918:38EDGARStatement of Changes in Beneficial Ownership (4)
5/23/201918:37EDGARStatement of Changes in Beneficial Ownership (4)
5/23/201918:36EDGARStatement of Changes in Beneficial Ownership (4)
5/23/201918:35EDGARStatement of Changes in Beneficial Ownership (4)
5/23/201918:34EDGARStatement of Changes in Beneficial Ownership (4)
5/22/201917:19EDGARCurrent Report Filing (8-k)
5/08/201917:33EDGARQuarterly Report (10-q)
5/08/201906:44EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NYSE
BHVN
Biohaven P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.